Remifentanil Hydrochloride Injection shortage
Current 9 presentations · 3 manufacturers · first FDA posting 2022-06-28 · last update 2026-10-15
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Demand increase for the drug
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 06/28/2022 Updated 10/06/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 06/28/2022 Updated 10/15/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 06/28/2022 Updated 10/15/2026 |
| Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 06/28/2022 Updated 10/14/2026 |
| Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 06/28/2022 Updated 10/14/2026 |
| Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 06/28/2022 Updated 10/14/2026 |
| Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted 06/28/2022 Updated 10/05/2026 | |
| Ultiva, Injection, 2 mg (NDC 72078-035-02) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted 06/28/2022 Updated 10/05/2026 | |
| Ultiva, Injection, 5 mg (NDC 72078-036-05) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted 06/28/2022 Updated 10/05/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)